Cargando…
HemaMax™, a Recombinant Human Interleukin-12, Is a Potent Mitigator of Acute Radiation Injury in Mice and Non-Human Primates
HemaMax, a recombinant human interleukin-12 (IL-12), is under development to address an unmet medical need for effective treatments against acute radiation syndrome due to radiological terrorism or accident when administered at least 24 hours after radiation exposure. This study investigated pharmac...
Autores principales: | Basile, Lena A., Ellefson, Dolph, Gluzman-Poltorak, Zoya, Junes-Gill, Katiana, Mar, Vernon, Mendonca, Sarita, Miller, Joseph D., Tom, Jamie, Trinh, Alice, Gallaher, Timothy K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3286478/ https://www.ncbi.nlm.nih.gov/pubmed/22383962 http://dx.doi.org/10.1371/journal.pone.0030434 |
Ejemplares similares
-
hHSS1: a novel secreted factor and suppressor of glioma growth located at chromosome 19q13.33
por: Junes-Gill, Katiana S., et al.
Publicado: (2010) -
Randomized comparison of single dose of recombinant human IL-12 versus placebo for restoration of hematopoiesis and improved survival in rhesus monkeys exposed to lethal radiation
por: Gluzman-Poltorak, Zoya, et al.
Publicado: (2014) -
Retroviral vectors encoding ADA regulatory locus control region provide enhanced T-cell-specific transgene expression
por: Trinh, Alice T, et al.
Publicado: (2009) -
Human hematopoietic signal peptide-containing secreted 1 (hHSS1) modulates genes and pathways in glioma: implications for the regulation of tumorigenicity and angiogenesis
por: Junes-Gill, Katiana S, et al.
Publicado: (2014) -
What's new in IL-12? Combination!
por: Lawrence, Chris E, et al.
Publicado: (2015)